CyberKnife Treatment in India for Iraqis: What You Need to Know Before You Travel

Author:- Dr. Dheeraj Bojwani Date Created:- 15-08-2026

For an Iraqi patient whose tumour is in a location that makes conventional surgery risky, close to the spinal cord, deep in the lung, or wrapped around blood vessels near the liver, CyberKnife treatment offers something genuinely different from either surgery or standard radiotherapy: it delivers highly focused radiation from many angles, tracking the tumour’s exact position in real time, without a single incision and without the metal head frame older radiosurgery techniques required. For the right patient, this can mean treating a tumour that would otherwise be called inoperable. I have spent 24 years guiding patients from across the Middle East, Africa, and South Asia through exactly this decision, and Iraqi families are an increasingly regular part of that work. What I tell every family calling from Baghdad, Basra, Erbil, or Sulaimani is the same thing I would tell my own relative: CyberKnife is not simply “radiation,” it is a specific robotic system that treats tumours anywhere in the body, not only the brain, and the hospital’s experience with your specific tumour location is what determines whether it is the right tool for your case. For a growing number of Iraqi families, once the options are compared honestly, that experience is found in India.

Healing Journeys of Iraqi Patients

Iraqi Patients Share Their Experience

Why Iraqi Patients Are Looking Beyond Iraq for CyberKnife Treatment

Iraq has made real investments in radiosurgery. Neuroscience Hospital in Iraq has treated over a thousand patients with Gamma Knife radiosurgery for brain lesions, a genuine and meaningful achievement. A CyberKnife radiotherapy centre is also under active construction in Karbala, part of the Warith International Cancer Institute, built with the explicit goal of bringing this specific technology to Iraqi patients for the first time.

Where the picture stands today, however, is that this CyberKnife project is still being built, not yet treating patients, and Gamma Knife technology already available in Iraq treats brain lesions only, using a fixed head frame, and cannot address tumours in the spine, lung, liver, or prostate the way CyberKnife’s frameless, whole-body system can. Bone marrow, pancreatic, and other extracranial tumours simply fall outside what Iraq’s current radiosurgery capacity was built to treat. For an Iraqi patient with a tumour outside the brain who is a genuine candidate for robotic radiosurgery today, rather than once a future facility opens, this is why a growing number of families now travel for CyberKnife treatment specifically, and India has become one of the most trusted destinations, not simply the cheapest one.

Why India Specifically for CyberKnife Treatment, Not Just Overseas

Iraqi families researching treatment abroad quickly discover several destinations: Turkey, Jordan, UAE, and India are all commonly mentioned in the same breath. It is worth being direct about why India stands apart for CyberKnife treatment specifically.

The first reason is established, high-volume experience. India’s leading CyberKnife centres have been operating for years rather than months, with radiation oncology and medical physics teams experienced across the full range of tumour types this technology treats, brain, spine, lung, liver, pancreas, and prostate, rather than a single tumour location.

The second reason is integration with a full cancer care ecosystem. Leading Indian centres offering CyberKnife also maintain surgical oncology, medical oncology, and conventional radiotherapy on the same campus, so a tumour board can genuinely compare CyberKnife against surgery or standard radiation for a specific case, rather than a family being steered toward whichever single technology a smaller centre happens to own.

The third reason is infrastructure built specifically for international patients, including Arabic-speaking coordinators and case managers who can review existing imaging remotely to confirm candidacy before a family ever travels. Finally, there is regulatory credibility: a large share of India’s leading cancer hospitals hold JCI or NABH accreditation, many radiation oncologists have trained or held fellowships in the UK, US, or Germany, and India’s government has built a dedicated medical visa category for foreign patients and one attendant.

Understanding the Cost Picture of CyberKnife Treatment in India

Cost is rarely the only reason a family chooses India, but it is almost always part of the conversation. The figures below reflect typical all-inclusive ranges for a full CyberKnife treatment course, covering planning imaging, the robotic radiosurgery sessions themselves, and routine follow-up. Costs vary by tumour location and the number of sessions required, so I always urge families to get a written, itemised estimate once imaging has confirmed candidacy.

What stands out is not simply that India is cheaper than the United States, the United Kingdom, or Germany. It is that India offers the same robotic radiosurgery platform and internationally trained radiation oncology teams at a fraction of Western prices, with transparent, package-based pricing that contrasts favourably with Western systems where a quoted “treatment cost” often excludes planning imaging or the full number of sessions actually required until the final bill arrives. Many hospitals also accept a partial advance deposit rather than full upfront payment, which is worth raising directly in the first consultation since it can meaningfully ease the financial planning involved in arranging funds from Iraq.

What CyberKnife Treatment in India Typically Looks Like

Patients often worry that any cancer treatment means a long hospital stay, but CyberKnife is largely an outpatient process. Having coordinated this journey for many patients, I find it helps enormously to see the process mapped out plainly before departure.

A typical CyberKnife patient can expect one to five treatment sessions delivered over one to two weeks, with no overnight hospital stay required between sessions, and a further short period in India for a final review before flying home, with a structured remote follow-up plan and imaging continuing afterward.

Factors Every Iraqi Patient Should Weigh Before Deciding CyberKnife Treatment in India

Beyond cost and destination, the Iraqi families I have advised over these 24 years tend to make better decisions, and face fewer complications, when they think through the following before booking anything.

A few of these deserve a specific note. Confirm directly that CyberKnife, rather than surgery or conventional radiotherapy, is genuinely the best option for your specific tumour, ideally through a tumour board discussion rather than a single specialist’s opinion. Existing imaging should be translated and shared digitally before travel, since a radiation oncologist needs to review this personally to confirm candidacy and plan the treatment. Families should also ask, in writing, exactly how many sessions are included in the quoted package, since the number required varies by tumour type and size, and confirm what happens if additional sessions are needed once treatment has begun.

A Closing Thought for Iraqi Families

CyberKnife offers a genuinely different option for tumours that surgery cannot safely reach, and that option deserves to be delivered by a team with real, established experience, not a facility still being built or a marketing brochure promising the lowest quoted price. What the evidence consistently shows is that for Iraqi families weighing where to go, India offers a genuinely rare combination: years of established CyberKnife experience across the full range of tumour locations, integration with complete cancer care, meaningfully lower cost, and hospital systems built to confirm candidacy honestly before a family ever travels. Few destinations available to an Iraqi family today can offer this breadth of established robotic radiosurgery experience at once. My role, and the role of any advisor a family works with, should be to help confirm whether CyberKnife genuinely fits the patient’s specific tumour and make sure the plan in front of them fits their budget and timeline. Iraq’s families deserve the same standard of scrutiny and care in this decision as any family anywhere else in the world.

Sources & Further Reading

• World Health Organization — Iraq Health System Profile (who.int/countries/irq)
• National Institute for Health and Care Excellence (NICE, UK) — Stereotactic Radiosurgery Guidance (nice.org.uk)
• UK Government — List of English-Speaking Doctors and Medical Facilities in Iraq (gov.uk/government/publications/iraq-doctors-and-medical-facilities)
• National Cancer Institute (NCI, US) — Radiation Therapy for Cancer (cancer.gov)
• World Bank — Iraq Health Sector Reports (worldbank.org/en/country/iraq)

Frequently Asked Questions by Iraqi Patients about CyberKnife Treatment in India